- Home
- SLGB vs ABVC Comparison
SLGB vs ABVC Comparison
Compare SLGB & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGB | ABVC |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Hong Kong | United States |
| Employees | 68 | N/A |
| Industry | Integrated Freight & Logistics | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5M | 34.6M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | SLGB | ABVC |
|---|---|---|
| Price | $0.67 | $1.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 124.2K |
| Earning Date | 05-16-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $29.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.88 |
| 52 Week High | $6.02 | $4.02 |
Technical Indicators
Market Signals| Indicator | SLGB | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 53.11 | 56.26 |
| Support Level | $0.49 | $0.96 |
| Resistance Level | $1.63 | $1.47 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 21.11 | 54.33 |
Price Performance
Historical ComparisonAbout SLGB Smart Logistics Global Limited Ordinary Shares
Smart Logistics Global Ltd is a contract logistics solution provider in the PRC. The company focuses on industrial raw materials line-haul transportation business. The group focuses on developing a road-transport smart logistics digital ecosystem through innovation, digital analytics, and infrastructure establishment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.